How many insider declarations has Israel Biotech Fund I, L.P. filed?

Israel Biotech Fund I, L.P. has filed 3 public insider declarations with SEC (Form 4).

What is Israel Biotech Fund I, L.P.'s role?

Israel Biotech Fund I, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does Israel Biotech Fund I, L.P. report trades for?

Israel Biotech Fund I, L.P. reports trades for Ayala Pharmaceuticals, Inc..

← Executives ★ Sign in to follow

IB

Israel Biotech Fund I, L.P.

·SEC (Form 4)

Ayala Pharmaceuticals, Inc.

0

申报总数

0

公司

—

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by Israel Biotech Fund I, L.P.. Officer active across 1 company, notably Ayala Pharmaceuticals, Inc.. Aggregated, 3 filings have been recorded. Breakdown: 2 buys · 0 sell. History available since 18 October 2023. The latest transaction was filed on 7 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Israel Biotech Fund I, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Ayala Pharmaceuticals, Inc. (US)

申报3 总计

◇

Israel Biotech Fund I, L.P.

Director高管2024年2月7日Ayala Pharmaceuticals, Inc.

US$770,48823SEC ↗

1,926,221 股@ US$0.40100.0% 占其流量Common Stock, par value $0.001 per shareSEC:0001178913-24-000480:0

▲

Israel Biotech Fund I, L.P.

高管2023年10月18日Ayala Pharmaceuticals, Inc.

0SEC ↗

658,858 股0Common Stock, par value $0.001 per shareSEC:0001178913-23-003462:0

标准退出：2024年1月16日 (T+90)

▲

Israel Biotech Fund I, L.P.

10% Owner高管2023年10月18日Ayala Pharmaceuticals, Inc.

0SEC ↗

658,858 股0Common Stock, par value $0.001 per shareSEC:0001178913-23-003462:1

标准退出：2024年1月16日 (T+90)

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

IB

Israel Biotech Fund I, L.P.

·SEC (Form 4)

Ayala Pharmaceuticals, Inc.

0

申报总数

0

公司

—

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by Israel Biotech Fund I, L.P.. Officer active across 1 company, notably Ayala Pharmaceuticals, Inc.. Aggregated, 3 filings have been recorded. Breakdown: 2 buys · 0 sell. History available since 18 October 2023. The latest transaction was filed on 7 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.